
Breckenridge Pharmaceutical is recalling one lot of 60 mg propranolol hydrochloride extended-release capsules over possible metal contamination.
The affected 100-count bottles carry lot number PK25110035 and expire in May 2029.
Patients should stop using the recalled capsules and promptly contact their healthcare provider for replacement instructions, the company said.
Breckenridge Pharmaceutical is recalling capsules manufactured by Adare Pharma Solutions. The companys press release warned that possible metal contamination could cause cuts in the mouth, esophagus, stomach, or intestines.
The concern arose after metal was found in another lot that never reached the market. The recalled capsules shared material suspected of causing that contamination. Breckenridge reported no known related adverse events.
Author: Mark Huffman
Source: Consumer Affairs
Posted: 2026-11-18 13:53:24









